V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310008117 | 310005245 | 1.62 | 72 | Curative (C) | 2015-12-07 | 2015-12-08 | EOX | N | N | 310024524 | TOPOTECAN |
| 310008118 | 310008304 | 1.67 | null | Palliative (P) | 2014-11-30 | 2014-12-02 | Topotecan (intravenous) | N | N | 310024524 | AZACITIDINE |
| 310008119 | 310005246 | 1.8 | 58.6 | Palliative (P) | 2015-09-28 | 2016-03-29 | EOX | N | N | 310024532 | LENALIDOMIDE |
| 310008120 | 310005248 | 1.83 | 71.1 | Not known (9) | 2014-03-24 | 2014-03-25 | Retinoblastoma JOE | N | N | 310024541 | R-EPOCH |
| 310008121 | 310005249 | 1.6 | 91.7 | Curative (C) | 2017-01-22 | 2017-06-11 | DHAP - R | null | N | 310024541 | TEMOZOLOMIDE |
| 310008122 | 310005253 | 1.65 | 99.8 | Palliative (P) | null | 2014-06-19 | CYCLO + ETOPOSIDE + NELARABINE | 02 | null | 310024543 | METHOTREXATE HIGH DOSE |
| 310008123 | 310005256 | 1.57 | 60 | Adjuvant (A) | 2018-09-05 | 2018-09-08 | Olaparib | N | N | 310024563 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 310008124 | 310005257 | 1.79 | null | Curative (C) | 2015-09-07 | 2015-09-10 | Irinotecan + Modified De Gramont | 2 | N | 310024564 | IVA |
| 310008125 | 310008308 | null | 84 | Palliative (P) | 2014-08-05 | 2014-09-11 | Capecitabine (14 days)+Carboplatin | N | N | 310024569 | CETUXIMAB + RT |
| 310008126 | 310005258 | 0 | 50 | Not known (9) | 2016-01-19 | 2016-01-19 | Trastuzumab Subcutaneous | 2 | N | 310024576 | IRINOTECAN + MDG |
| 310008127 | 310005258 | 0 | null | Palliative (P) | 2018-05-23 | 2018-05-23 | Ifosfamide PVI 1g/m2 14day | Y | N | 310024576 | FEC |
| 310008128 | 310005258 | 1.75 | 62.2 | Curative (C) | 2017-01-14 | 2017-03-14 | MITOMYCIN | N | N | 310024576 | CAV |
| 310008129 | 310009934 | 1.87 | null | Curative (C) | 2017-03-20 | 2017-07-28 | Dacarbazine | N | null | 310024602 | ECX |
| 310008130 | 310008311 | 1.78 | 79.6 | Palliative (P) | null | 2018-02-21 | Gemcitabine + Oxaliplatin | N | null | 310024631 | IMATINIB |
| 310008131 | 310010810 | null | 78.4 | null | 2018-03-30 | 2018-04-22 | Triple / Double Intrathecal Therapy | 02 | N | 310024633 | TRASTUZUMAB |
| 310008132 | 310005268 | 1.62 | 86 | Palliative (P) | 2017-11-23 | 2017-12-18 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + METHOTREXATE | N | N | 310024647 | MERCAPTOPURINE + METHOTREXATE |
| 310008133 | 310008314 | 1.61 | null | Curative (C) | 2014-06-29 | 2014-07-09 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | 310024652 | RMS 2005 TRIAL |
| 310008134 | 310009936 | 1.65 | 78.4 | Curative (C) | 2013-03-27 | 2013-03-27 | Olaparib | 2 | N | 310024659 | CISPLATIN + ETOPOSIDE |
| 310008135 | 310005269 | 1.48 | null | null | null | 2014-09-05 | Irinotecan + Modified De Gramont | 99 | null | 310024669 | CYCLO + DOXORUBICIN + VINCRISTINE |
| 310008136 | 310005270 | 1.72 | 80.8 | Palliative (P) | 2017-12-04 | 2017-12-04 | Carboplatin + Docetaxel | N | N | 310024670 | DOXORUBICIN |
| 310008137 | 310005270 | 1.65 | 120 | Palliative (P) | 2016-12-02 | 2017-01-30 | Sunitinib | N | N | 310024670 | IFOSFAMIDE |
| 310008138 | 310005270 | 1.61 | 58.6 | Palliative (P) | 2017-01-20 | 2017-02-18 | Atezolizumab | N | N | 310024670 | IRINOTECAN + MDG |
| 310008139 | 310005270 | 1.7 | 76.4 | Palliative (P) | 2017-10-05 | 2017-11-11 | DABRAFENIB | N | N | 310024670 | ICE |
| 310008140 | 310005270 | 0 | 47.1 | Palliative (P) | 2015-07-26 | 2015-08-01 | Mitotane 2g | Y | N | 310024670 | IGEV |
| 310008141 | 310005270 | null | 70.8 | Neo-adjuvant (N) | 2014-11-14 | 2015-04-03 | Atezolizumab | 02 | N | 310024670 | METHOTREXATE HIGH DOSE |
| 310008142 | 310005270 | null | 108 | Curative (C) | 2015-12-05 | 2015-12-05 | DOXORUBICIN | N | N | 310024670 | CAPECITABINE + CARBOPLATIN |
| 310008143 | 310005271 | 1.85 | 83.3 | Palliative (P) | 2017-12-17 | 2017-12-17 | PEG INTERFERON | N | N | 310024801 | METHOTREXATE HIGH DOSE |
| 310008144 | 310005272 | 1.53 | 85.6 | Palliative (P) | 2017-11-12 | 2017-11-12 | Temozolomide 200mg/m2 | 02 | N | 310024806 | EOX |
| 310008145 | 310005272 | 1.79 | 64.3 | Palliative (P) | 2014-04-17 | 2014-04-25 | Irinotecan + Modified De Gramont | Y | N | 310024806 | SELPAC TRIAL |
| 310008146 | 310009938 | 1.29 | 106 | Disease modification (D) | 2016-05-14 | 2016-05-21 | ECX | N | N | 310024826 | CETUXIMAB |
| 310008147 | 310005275 | 1.47 | 60.7 | Adjuvant (A) | 2017-09-01 | 2017-10-02 | Alemtuzumab | 01 | N | 310024828 | DOXORUBICIN |
| 310008148 | 310005277 | null | 94.3 | Disease modification (D) | 2016-07-27 | 2016-07-31 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 310024839 | GEMCITABINE + VINORELBINE |
| 310008149 | 310005280 | 1.81 | null | Palliative (P) | 2016-08-11 | 2016-08-11 | Bendamustine + prednisolone | N | N | 310024845 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 310008150 | 310005281 | 1.64 | 87.3 | Curative (C) | 2018-04-17 | 2018-04-17 | NIVOLUMAB | N | N | 310024848 | ICE |
| 310008151 | 310008322 | 0 | 77.7 | Palliative (P) | 2016-01-31 | 2016-01-31 | Sunitinib | 02 | N | 310024859 | CEV |
| 310008152 | 310008323 | 1.84 | 23.6 | Palliative (P) | null | 2017-09-23 | METHOTREXATE | N | N | 310024862 | CETUXIMAB + RT |
| 310008153 | 310008323 | 1.82 | 108 | Palliative (P) | 2016-01-26 | 2016-02-03 | PEG INTERFERON | 01 | N | 310024862 | OXALIPLATIN + MDG |
| 310008154 | 310011586 | 1.75 | 91 | Curative (C) | 2013-10-11 | 2013-11-08 | Alemtuzumab | 02 | N | 310024868 | CAPECITABINE |
| 310008155 | 310011586 | 1.72 | 85.3 | Curative (C) | 2014-07-18 | 2014-08-01 | Vemurafenib | N | N | 310024868 | IMATINIB |
| 310008156 | 310005284 | 1.65 | null | Palliative (P) | 2015-08-11 | 2015-09-05 | LENALIDOMIDE | 2 | N | 310024887 | CAPECITABINE + OXALIPLATIN |
| 310008157 | 310005285 | null | null | Curative (C) | 2014-12-07 | 2015-04-03 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | N | N | 310024896 | CTD |
| 310008158 | 310008324 | 1.84 | 96.4 | Disease modification (D) | 2015-02-07 | 2015-02-08 | Ifosfamide | N | N | 310024907 | ICE |
| 310008159 | 310005288 | 1.6 | 50 | Palliative (P) | 2014-02-16 | 2014-07-01 | Doxorubicin + Olaratumab | 02 | N | 310024917 | CISPLATIN + ETOPOSIDE |
| 310008161 | 310009943 | 1.52 | 20.4 | Palliative (P) | 2017-11-13 | 2017-11-17 | Pemetrexed | 02 | N | 310024928 | TEMOZOLOMIDE |
| 310008162 | 310005289 | 1.77 | 76.5 | Curative (C) | 2017-04-05 | 2017-04-09 | Capecitabine (21 day) + Irinotecan | N | N | 310024932 | CAV |
| 310008163 | 310005290 | null | 68 | Neo-adjuvant (N) | 2015-03-26 | 2015-04-02 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 310024932 | PEMETREXED |
| 310008164 | 310010815 | 1.77 | null | null | 2013-12-27 | 2014-01-03 | Vemurafenib | 2 | N | 310024934 | CISPLATIN + ETOPOSIDE |
| 310008165 | 310005294 | 1.78 | 91.5 | Palliative (P) | 2016-08-06 | 2016-08-07 | PEG INTERFERON | N | N | 310024937 | IVAC |
| 310008166 | 310011317 | null | 77 | Curative (C) | 2016-12-24 | 2016-12-25 | Cytarabine HD + Methotrexate HD | 02 | N | 310024938 | ICE-R |
| 310008167 | 310011317 | null | 65.9 | Palliative (P) | 2017-09-12 | 2017-09-25 | Gemcitabine + Oxaliplatin | N | N | 310024938 | REGORAFENIB |